查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1634212

全球 PEEK 椎間器材市場 - 2025 - 2033

Global PEEK Interbody Devices Market - 2025 - 2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球PEEK椎間器械市場規模達25億美元，預計2033年將達到46億美元，2025-2033年預測期間複合年成長率為7.4%。

PEEK（聚醚醚酮）椎間裝置是由高性能熱塑性聚合物製成的醫療植入物，專為脊椎手術而設計。這些裝置主要用於脊椎融合手術，透過取代受損或退化的椎間盤並促進相鄰椎骨的融合來幫助穩定脊椎。 PEEK 是一種生物相容性聚合物，以其優異的機械性能而聞名，包括高強度、剛度以及耐磨性和耐分解性。

PEEK 椎間融合器最常用於前路頸椎間盤切除融合術(ACDF)、腰椎椎間融合術(LIF)、後路腰椎椎間融合術(PLIF) 和經椎間孔腰椎椎間融合術(TLIF ) 手術。它們的目的是在癒合和融合過程中提供長期支持。

由於脊椎手術的進步、不斷成長的醫療保健需求以及 PEEK 作為經過科學分析的材料的獨特優勢，多年來，PEEK（聚醚醚酮）椎間器械的市場需求一直在穩步成長。例如，根據美國國立衛生研究院(NIH) 的數據，最終分析納入了5 項使用PEEK 椎間裝置的研究（146 名患者），其中包括1 項隨機對照試驗、2 項前瞻性研究和2 項回顧性研究。這 5 項研究中 PEEK 椎間裝置的融合率為 88% 至 98%。

市場動態：

驅動程式和限制

PEEK 椎間器械不斷進步的技術

PEEK 椎間設備不斷進步的技術進步極大地推動了市場的成長，預計將在預測期內推動市場的發展。這些進步提高了 PEEK 植入物的性能、客製化和多功能性，使其成為脊椎手術的首選。使用 3D 列印（積層製造）技術可以創建適合患者獨特脊椎解剖結構的個人化 PEEK 椎間設備。這提高了手術的準確性，減少了併發症，並提高了成功融合的機會。

例如，2024 年 6 月，領先的技術和製造公司 Curiteva, Inc. 在其經 FDA 批准的 Inspire Posterior Interbody Fusion Solutions 中推出了眾多產品中的第一個產品。這款採用 HAFUSE 技術的 3D 列印小梁 PEEK 椎間體專為提高經椎間孔腰椎手術的患者治療效果而開發，擁有最佳化的互連多孔結構，可促進骨骼向內生長並穿過整個裝置。

PEEK 的射線可透特性允許在手術後進行清晰的 X 光和 CT 掃描，這對於在不受金屬植入物干擾的情況下監測癒合過程至關重要。這比傳統的鈦植入物具有優勢，特別是對於長期監測。恢復期間和術後護理期間對精確監測的需求不斷成長，推動了 PEEK 植入物市場的成長。外科醫生更喜歡 PEEK，因為它能夠實現更好的成像，從而提高患者滿意度並減少併發症。

來自替代材料的競爭

來自替代材料的競爭是阻礙 PEEK 椎間器械市場成長的主要挑戰之一。儘管 PEEK 具有許多優點，但也用於脊椎融合手術的其他材料的可用性可能會限制其市場佔有率。由於其優異的骨整合特性、生物相容性和支持骨骼生長的能力，鈦仍然是脊椎植入物中最常用的材料之一。與 PEEK 不同，鈦具有促進骨骼生長的天然粗糙表面，通常可以實現更快、更有效的脊椎融合。

鈦基椎體間裝置是 PEEK 植入物的直接競爭對手，特別是對於需要提高融合率的患者。這些植入物在脊椎手術中擁有良好的記錄，使其成為 PEEK 的有力競爭對手。碳纖維增強 PEEK (CFR-PEEK) 裝置正在作為一種替代方案出現，它結合了 PEEK 和碳纖維的優點，可改善機械性能和患者治療效果。 CFRP 替代品在脊椎手術中的使用增加減少了對傳統 PEEK 設備的市場需求。

陶瓷基底植體以其優異的生物相容性和骨整合而聞名。這些材料能夠增強骨結合，並提供金屬和 PEEK 植入物的替代品，特別是在脊椎融合手術中。陶瓷在促進更好的骨骼生長和減少長期植入併發症方面具有競爭優勢。隨著它們在醫學界獲得認可，它們的採用可能會減少對 PEEK 椎間設備的需求。

生物可吸收材料（例如聚-L-乳酸和其他生物可吸收聚合物）是一類在脊椎外科手術中受到關注的新型材料，因為它們隨著時間的推移逐漸分解並被人體吸收。這消除了融合完成後進行植入物移除手術的需要，使它們成為對某些患者極具吸引力的替代方案。隨著生物可吸收植入物在強度和性能方面的提高，它們消除對永久性脊椎植入物的需求的能力使其成為 PEEK 設備日益成長的競爭對手。

有關此報告的更多詳細資訊 - 索取樣本

目錄

第1章：市場介紹和範圍

  • 報告的目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類的片段
  • 最終使用者的片段
  • 按地區分類的片段

第 3 章：動力學

  • 影響因素
    • 促進要素
      • PEEK 椎間器械技術不斷進步
    • 限制
      • 來自替代材料的競爭
    • 機會
    • 影響分析

第 4 章：策略洞察與產業展望

  • 市場領導者和先驅
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的知名領導者
    • 擁有成熟產品的市場領導者
  • 新興新創企業和關鍵創新者
  • CXO 觀點
  • 最新進展和突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：PEEK 椎間器械市場，依產品類型

  • 椎間融合器
  • 前路腰椎椎間融合器 (ALIF)
  • 極端橫向椎間融合裝置 (XLIF)
  • 後路腰椎間融合器 (PLIF)
  • 經椎間孔腰椎椎間融合器 (TLIF)
  • 其他

第 6 章：PEEK 椎間設備市場（依最終使用者）

  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他

第 7 章：PEEK 體內設備市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 8 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的主要發展
  • 公司基準化分析

第 9 章：公司簡介

  • Stryker Corporation
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
    • SWOT分析
  • Globus Medical, Inc.
  • B. Braun SE
  • Xtant Medical
  • Invibio Ltd.
  • ATEC Spine, Inc
  • Life Spine, Inc.
  • Orthofix Medical Inc.
  • Curiteva, Inc.
  • Intelivation Technologies

第 10 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 11 章：附錄

簡介目錄
Product Code: MD9026

The global PEEK interbody devices market reached US$ 2.5 billion in 2024 and is expected to reach US$ 4.6 billion by 2033, growing at a CAGR of 7.4% during the forecast period 2025-2033.

PEEK (Polyether Ether Ketone) interbody devices are medical implants made from a high-performance thermoplastic polymer, designed specifically for use in spinal surgeries. These devices are primarily used in spinal fusion procedures, where they help stabilize the spine by replacing damaged or degenerated intervertebral discs and promoting the fusion of adjacent vertebrae. PEEK is a biocompatible polymer known for its excellent mechanical properties, including high strength, stiffness, and resistance to wear and degradation.

PEEK interbody devices are most commonly used in anterior cervical discectomy and fusion (ACDF), lumbar interbody fusion (LIF), posterior lumbar interbody fusion (PLIF) and transforaminal lumbar interbody fusion (TLIF) surgeries. They are intended to provide long-term support during the healing and fusion process.

The market demand for PEEK (Polyether Ether Ketone) interbody devices has been steadily increasing over the years due to various factors related to advancements in spinal surgery, growing healthcare needs, and the unique benefits of PEEK as a material with scientific analysis. For instance, according to the National Institute of Health (NIH), five studies using PEEK interbody devices (146 patients) were included in the final analysis, including 1 randomized controlled trial, 2 prospective studies, and 2 retrospective studies. Rates of fusion for PEEK interbody devices in these 5 studies were 88% to 98%.

Market Dynamics: Drivers & Restraints

Rising technological advancements in PEEK interbody devices

The rising technological advancements in PEEK interbody devices are significantly driving the growth of the market and are expected to drive the market over the forecast period. These advancements are enhancing the performance, customization, and versatility of PEEK implants, making them a preferred choice in spinal surgeries. The use of 3D printing (additive manufacturing) technology allows for the creation of personalized PEEK interbody devices tailored to a patient's unique spinal anatomy. This improves the accuracy of surgeries, reduces complications, and enhances the chances of successful fusion.

For instance, in June 2024, Curiteva, Inc., a leading technology and manufacturing company, commercially launched the first of many offerings in its FDA-cleared Inspire Posterior Interbody Fusion Solutions. Developed to enhance patient outcomes of transforaminal lumbar procedures, this 3D Printed Trabecular PEEK with HAFUSE Technology interbody boasts an optimized interconnected porous structure, promoting bone ingrowth into and through the entire device.

PEEK's radiolucent properties allow for clear X-ray and CT scans post-surgery, which is crucial for monitoring the healing process without interference from metallic implants. This provides an advantage over traditional titanium implants, particularly for long-term monitoring. The increasing demand for precise monitoring during recovery and post-operative care is pushing the growth of PEEK implants in the market. Surgeons prefer PEEK for its ability to allow for better imaging, leading to greater patient satisfaction and fewer complications.

Competition from alternative materials

Competition from alternative materials is one of the key challenges hampering the growth of the PEEK interbody devices market. Although PEEK offers many advantages, the availability of other materials that are also used for spinal fusion surgeries can limit its market share. Titanium remains one of the most commonly used materials in spinal implants due to its superior osseointegration properties, biocompatibility, and ability to support bone growth. Unlike PEEK, titanium has natural rough surfaces that encourage bone growth, often leading to quicker and more effective spinal fusion.

Titanium-based interbody devices are a direct competitor to PEEK implants, particularly for patients who require enhanced fusion rates. These implants have a proven track record in spinal surgeries, making them a strong competitor for PEEK. Carbon fiber-reinforced PEEK (CFR-PEEK) devices are emerging as an alternative, combining the benefits of PEEK and carbon fiber for improved mechanical properties and patient outcomes. This increased use of CFRP alternatives in spinal surgeries reduces the market demand for traditional PEEK devices.

Ceramic-based implants are known for their excellent biocompatibility and osseointegration. These materials offer the ability to enhance bone bonding and provide an alternative to both metal and PEEK implants, particularly in spinal fusion surgeries. Ceramics offer a competitive edge in terms of promoting better bone growth and reducing long-term implant complications. As they gain recognition in the medical community, their adoption may reduce demand for PEEK interbody devices.

Bioresorbable materials (such as poly-L-lactic acid and other bioabsorbable polymers) are a new class of materials gaining attention in spinal surgery because they gradually break down and are absorbed by the body over time. This eliminates the need for implant removal surgery after fusion is complete, making them a highly attractive alternative for some patients. As bioresorbable implants improve in terms of strength and performance, their ability to eliminate the need for permanent spinal implants positions them as a growing competitor to PEEK devices.

For more details on this report - Request for Sample

Segment Analysis

The global PEEK interbody devices market is segmented based on product type, end-user and region.

Product Type:

The posterior lumbar interbody fusion devices segment is expected to dominate the PEEK interbody devices market share

One of the most notable benefits of using PEEK in posterior lumbar interbody fusion (PLIF) surgeries is its radiolucency. PEEK allows for clear post-surgical imaging (X-rays, CT scans), enabling better monitoring of the healing process without interference from the implant. This is particularly valuable in PLIF, where precise imaging is crucial to ensure the fusion process is proceeding correctly.

The adoption of minimally invasive spine surgery techniques, including minimally invasive PLIF (MIS-PLIF), is growing globally, especially in developed regions like the U.S. and Europe. PEEK's compatibility with minimally invasive spine surgery, due to its precise fit and ease of use, is fueling its dominance in posterior lumbar interbody fusion surgeries.

The growing preference for minimally invasive procedures, which involve smaller incisions and quicker recovery times, is driving the demand for PEEK interbody devices, particularly in PLIF surgeries, as they help enhance success rates and reduce surgical complications. Thus, many market players and emerging startups are focussing on the development of posterior interbody fusion devices with advanced features.

For instance, in October 2021, NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, launched the Cohere TLIF-O implant and the Cohere TLIF-A implant. With these additions to its Advanced Materials Science (AMS) portfolio, NuVasive is the only company to offer both porous PEEK and porous titanium implants for posterior spine surgery.

Geographical Analysis

North America is expected to hold a significant position in the PEEK interbody devices market share

North America, particularly the United States has a high incidence of degenerative disc disease, herniated discs and other spinal disorders, which drive the demand for spinal surgeries, including those using PEEK interbody devices. The aging population and lifestyle-related conditions contribute to the growing prevalence of spinal issues.

Additionally, according to the National Institute of Health (NIH), approximately 900,000 American and 30,000 Canadian adults undergo spine surgery annually. This rising number of spinal surgeries in North America especially in the United States and Canada directly boosts the demand for PEEK interbody devices, making the region the largest market for these implants.

The United States leads in the adoption of advanced surgical techniques such as minimally invasive spine surgery, which requires highly precise and biocompatible materials like PEEK. The use of PEEK interbody devices in PLIF (Posterior Lumbar Interbody Fusion) and other spinal fusion procedures is common in MISS due to its strength, radiolucency, and compatibility with modern imaging techniques.

Asia-Pacific is growing at the fastest pace in the PEEK interbody devices market

As the population in Asia-Pacific countries ages and urbanization increases, the incidence of spinal disorders such as degenerative disc disease, scoliosis, and herniated discs is rising. This has resulted in greater demand for spinal surgeries, including posterior lumbar interbody fusion (PLIF), anterior lumbar interbody fusion (ALIF), and other spinal fusion procedures that require interbody devices like PEEK. According to Clearstate, in 2022, an estimated total of 47k implanted spinal procedures were performed across SEA countries. As spinal procedures are growing in the region, many market players are expanding their spinal portfolio into PEEK interbody devices market.

For instance, in June 2022, an established strategic partnership between Beijing Fule and Invibio Biomaterial Solutions has resulted in the development of a new generation of interbody fusion devices, the first such high-performance material medical fusion cage product based upon PEEK-OPTIMATM HA Enhanced polymers in China.

Over the past decade, countries in APAC, such as India, China, Japan, and South Korea, have significantly improved their healthcare infrastructure. The adoption of advanced medical technologies like PEEK interbody devices has been a major factor in this growth. Many hospitals and surgical centers now offer world-class spine surgeries using cutting-edge technologies. APAC countries, particularly India, Thailand, and Singapore, have become global hubs for medical tourism due to cost-effective treatments combined with high-quality healthcare services. Spinal surgeries, including those using PEEK devices, are increasingly popular among medical tourists from the U.S., Europe, and the Middle East.

Competitive Landscape

The major global players in the PEEK interbody devices market include Stryker Corporation, Globus Medical, Inc., B. Braun SE, Xtant Medical, Invibio Ltd., ATEC Spine, Inc., Life Spine, Inc, Orthofix Medical Inc., Curiteva, Inc., Intelivation Technologies and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global PEEK interbody devices market report delivers a detailed analysis with 54 key tables, more than 46 visually impactful figures, and 147 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by End-User
  • 2.5. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements in PEEK Interbody Devices
    • 3.1.2. Restraints
      • 3.1.2.1. Competition From Alternative Materials
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. PEEK Interbody Devices Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Interbody Fusion Devices*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Anterior Lumbar Interbody Fusion Devices (ALIF)
  • 5.4. Extreme Lateral Interbody Fusion Devices (XLIF)
  • 5.5. Posterior Lumbar Interbody Fusion Devices (PLIF)
  • 5.6. Transforaminal Lumbar Interbody Fusion Devices (TLIF)
  • 5.7. Others

6. PEEK Interbody Devices Market, By End-User

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 6.1.2. Market Attractiveness Index, By End-User
  • 6.2. Hospitals*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Specialty Clinics
  • 6.4. Ambulatory Surgical Centers
  • 6.5. Others

7. PEEK Interbody Devices Market, By Regional Market Analysis and Growth Opportunities

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 7.1.2. Market Attractiveness Index, By Region
  • 7.2. North America
    • 7.2.1. Introduction
    • 7.2.2. Key Region-Specific Dynamics
    • 7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.2.5.1. U.S.
      • 7.2.5.2. Canada
      • 7.2.5.3. Mexico
  • 7.3. Europe
    • 7.3.1. Introduction
    • 7.3.2. Key Region-Specific Dynamics
    • 7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.3.5.1. Germany
      • 7.3.5.2. U.K.
      • 7.3.5.3. France
      • 7.3.5.4. Spain
      • 7.3.5.5. Italy
      • 7.3.5.6. Rest of Europe
  • 7.4. South America
    • 7.4.1. Introduction
    • 7.4.2. Key Region-Specific Dynamics
    • 7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.4.5.1. Brazil
      • 7.4.5.2. Argentina
      • 7.4.5.3. Rest of South America
  • 7.5. Asia-Pacific
    • 7.5.1. Introduction
    • 7.5.2. Key Region-Specific Dynamics
    • 7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.5.5.1. China
      • 7.5.5.2. India
      • 7.5.5.3. Japan
      • 7.5.5.4. South Korea
      • 7.5.5.5. Rest of Asia-Pacific
  • 7.6. Middle East and Africa
    • 7.6.1. Introduction
    • 7.6.2. Key Region-Specific Dynamics
    • 7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

8. Competitive Landscape and Market Positioning

  • 8.1. Competitive Overview and Key Market Players
  • 8.2. Market Share Analysis and Positioning Matrix
  • 8.3. Strategic Partnerships, Mergers & Acquisitions
  • 8.4. Key Developments in Product Portfolios and Innovations
  • 8.5. Company Benchmarking

9. Company Profiles

  • 9.1. Stryker Corporation*
    • 9.1.1. Company Overview
    • 9.1.2. Product Portfolio and Description
    • 9.1.3. Financial Overview
    • 9.1.4. Key Developments
    • 9.1.5. SWOT Analysis
  • 9.2. Globus Medical, Inc.
  • 9.3. B. Braun SE
  • 9.4. Xtant Medical
  • 9.5. Invibio Ltd.
  • 9.6. ATEC Spine, Inc
  • 9.7. Life Spine, Inc.
  • 9.8. Orthofix Medical Inc.
  • 9.9. Curiteva, Inc.
  • 9.10. Intelivation Technologies

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

  • 10.1. Data Collection Methods
  • 10.2. Data Triangulation
  • 10.3. Forecasting Techniques
  • 10.4. Data Verification and Validation

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us